Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-04-22 @ 4:27 PM
Study NCT ID:
NCT06033820
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2023-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL
Sponsor:
RenJi Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT-2022-0229
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None